Kushagr Punyani - Diagonal Bio Founding Advisor
| DIABIO Stock | 0.03 0 4.98% |
Insider
Kushagr Punyani is Founding Advisor of Diagonal Bio AB
| Age | 32 |
| Phone | 46 7 35 26 27 59 |
| Web | https://diagonalbio.com |
Diagonal Bio Management Efficiency
The company has return on total asset (ROA) of (0.2687) % which means that it has lost $0.2687 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5241) %, meaning that it generated substantial loss on money invested by shareholders. Diagonal Bio's management efficiency ratios could be used to measure how well Diagonal Bio manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Tina Hultkvist | AB Volvo | 49 | |
| Helena Saxon | Investor AB ser | 53 | |
| Johan MSc | Investor AB ser | 52 | |
| Aradhana MD | AstraZeneca PLC | 48 | |
| Jessica Hggstrm | Investor AB ser | 54 | |
| Joachim Rosenberg | AB Volvo | 53 | |
| Geert Follens | Atlas Copco AB | 64 | |
| Paolo Guglielmini | Hexagon AB | 46 | |
| Andrew Walker | Atlas Copco AB | 62 | |
| Chris Sheldon | AstraZeneca PLC | N/A | |
| Mats Rahmstrm | Atlas Copco AB | 58 | |
| Tina Hultkvist | AB Volvo | 49 | |
| Magnus Dalhammar | Investor AB ser | N/A | |
| Sofia Frandberg | AB Volvo | 59 | |
| Roger Alm | AB Volvo | 61 | |
| Lars Eklof | Atlas Copco AB | N/A | |
| Joachim Rosenberg | AB Volvo | 53 | |
| Petra Hedengran | Investor AB ser | 59 | |
| Scott Rafkin | AB Volvo | 54 | |
| Scott Rafkin | AB Volvo | 54 | |
| Cecilia Sandberg | Atlas Copco AB | 55 | |
Management Performance
| Return On Equity | -0.52 | |||
| Return On Asset | -0.27 |
Diagonal Bio AB Leadership Team
Elected by the shareholders, the Diagonal Bio's board of directors comprises two types of representatives: Diagonal Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Diagonal. The board's role is to monitor Diagonal Bio's management team and ensure that shareholders' interests are well served. Diagonal Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Diagonal Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Per Heander, Chief Officer | ||
| Johan Kallstrand, Founding Partner | ||
| Kushagr Punyani, Founding Advisor | ||
| Andreas Nyberg, Founder Officer | ||
| Jack Madsen, Chief Officer |
Diagonal Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Diagonal Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.52 | |||
| Return On Asset | -0.27 | |||
| Operating Margin | (3.67) % | |||
| Current Valuation | 112.69 K | |||
| Shares Outstanding | 34.77 M | |||
| Shares Owned By Insiders | 14.74 % | |||
| Price To Book | 0.50 X | |||
| Price To Sales | 3.26 X | |||
| Revenue | 407 K | |||
| Gross Profit | (85 K) |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Diagonal Stock
Diagonal Bio financial ratios help investors to determine whether Diagonal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diagonal with respect to the benefits of owning Diagonal Bio security.